END STAGE COVID AND ASHERSON’S SYNDROME

Concerns that Catastrophic Antiphospholipid Syndrome may be the result of multiple infections/exposures to the Spike Protein of SARS-CoV-2

July 5, 2022

Before I began posting on Twitter and Substack, I corresponded with several MD/PhDs around the world. I hypothesized that the immense peptide sharing of the Spike Protein would induce a progressive autoimmune disease which would inevitably result in Asherson’s Syndrome (Catastrophic Antiphospholipid Syndrome) for all over time, due to reinfections and exposures to the Spike Protein. I still believe, unfortunately, it is the case.

This to me is extremely alarming, and provides evidence for my hypothesis:

Catastrophic antiphospholipid syndrome complicated with essential thrombocythaemia after COVID-19 vaccination: in search of the underlying mechanism

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665448/

I believe I have already discovered the underlying mechanism.

Please read the email I sent to an MD/PhD back in December of 2020, at the beginning of the rollout.

0f926bd8-5fd5-4704-99c9-eaf06004b4ca_612x723
5bea4814-3475-4bf7-8d4d-fd5684a30f5d_612x726
7c40bc9b-d474-4449-a50c-7fd2694e8c3e_612x736